VITANOVA BIOMEDICAL, INC. — Form D/A
VITANOVA BIOMEDICAL, INC. of KERRVILLE, TX, a company, filed a Form D amendment with the SEC on 2021-06-08. The offering totals $6.5M, of which $325K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2021-06-08
- Form: D/A
- Accession: 0001567619-21-011828
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $6.5M
- Amount sold: $325K
- Remaining: $6.2M
- Minimum investment: $25K
- Investors: 5
- Date of first sale: 2019-08-26
- Security types: equity, debt
- Revenue range: Decline to Disclose
- SEC file number: 021-347578
Issuer
- Name: VITANOVA BIOMEDICAL, INC.
- CIK: 0001776700
- Entity type: Corporation
- Jurisdiction: TEXAS
- Incorporated: 2014
- Address: 222 SIDNEY BAKER ST., KERRVILLE, TX, 78028
- Phone: 317-730-5955
Officers, directors & promoters (12)
| Name | Role | Location |
|---|
| GREG CO VITANOVA BIOMEDICAL INC ESPENHOVER | Director | KERRVILLE, TX |
| MATTHEW CO VITANOVA BIOMEDICAL INC GDOVIN | Director | KERRVILLE, TX |
| THOMAS CO VITANOVA BIOMEDICAL INC ROBERTS | Director | KERRVILLE, TX |
| GREG CO VITANOVA BIOMEDICAL INC ESPENHOVER | Executive Officer | KERRVILLE, TX |
| MATTHEW CO VITANOVA BIOMEDICAL INC GDOVIN | Executive Officer | KERRVILLE, TX |
| THOMAS CO VITANOVA BIOMEDICAL INC ROBERTS | Executive Officer | KERRVILLE, TX |
| Thomas Roberts | Director | Denver, CO |
| Thomas Roberts | Executive Officer | Denver, CO |
| GREG ESPENHOVER | Director | KERRVILLE, TX |
| GREG ESPENHOVER | Executive Officer | KERRVILLE, TX |
| MATTHEW GDOVIN | Director | KERRVILLE, TX |
| MATTHEW GDOVIN | Executive Officer | KERRVILLE, TX |
Other filings by this issuer (5)
More